OS Therapies (NYSE:OSTX) Stock Price Up 5.1% – Time to Buy?

OS Therapies Inc (NYSE:OSTX) traded up 5.1% on Friday . The company traded as high as $2.06 and last traded at $1.95. 20,692 shares traded hands during mid-day trading, a decline of 85% from the average session volume of 133,760 shares. The stock had previously closed at $1.86.

Analysts Set New Price Targets

OSTX has been the topic of several recent research reports. Brookline Capital Management raised OS Therapies to a “strong-buy” rating in a report on Thursday, August 22nd. EF Hutton Acquisition Co. I raised OS Therapies to a “strong-buy” rating in a research note on Tuesday, September 3rd.

OS Therapies Stock Up 5.1 %

The company’s 50-day moving average price is $2.84.

Hedge Funds Weigh In On OS Therapies

An institutional investor recently bought a new position in OS Therapies stock. Virtu Financial LLC bought a new position in shares of OS Therapies Inc (NYSE:OSTX) during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 10,045 shares of the company’s stock, valued at approximately $28,000.

OS Therapies Company Profile

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. Its pipeline includes OST-HER2, an off-the-shelf immunotherapy for osteosarcoma patients; and OST-tunable drug conjugate (OST-tADC), an antibody-drug conjugate technology, with a plug-and-play platform that features tunable pH sensitive silicone linkers.